US Stock MarketDetailed Quotes

INCY Incyte

Watchlist
  • 62.080
  • -0.700-1.12%
Close Mar 25 16:00 ET
  • 62.080
  • 0.0000.00%
Post 20:01 ET
12.01BMarket Cap413.87P/E (TTM)

About Incyte Company

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.

Company Profile

SymbolINCY
Company NameIncyte
Listing DateNov 4, 1993
Issue Price7.50
Founded1991
CEOMr. Herve Hoppenot
MarketNASDAQ
Employees2617
Fiscal Year Ends12-31
Address1801 Augustine Cut-Off
CityWilmington
ProvinceDelaware
CountryUnited States of America
Zip Code19803
Phone1-302-498-6700
Websitehttp://www.incyte.com

Company Executives

  • Name
  • Position
  • Salary
  • Herve Hoppenot
  • Chairman of the Board, President and Chief Executive Officer
  • 16.66M
  • Thomas Tray
  • Vice President and Chief Accounting Officer
  • --
  • Christiana Stamoulis, M.B.A.
  • Executive Vice President and Chief Financial Officer
  • 5.08M
  • Dr. Steven H. Stein, M.D.
  • Executive Vice President and Chief Medical Officer
  • 5.63M
  • Barry P. Flannelly, Pharm.D.
  • Executive Vice President and General Manager, North America
  • 4.09M
  • Matteo Trotta
  • Executive Vice President and General Manager, Dermatology US
  • --
  • Lee Heeson
  • Executive Vice President, Incyte International
  • --
  • Mohamed Khairie Issa
  • Executive Vice President and Head of US Oncology
  • --
  • Vijay K. Iyengar
  • Executive Vice President, Global Strategy and Corporate Development
  • --
  • Sheila A Denton
  • Executive Vice President, General Counsel and Corporate Secretary
  • --
  • Paula J. Swain
  • Executive Vice President, Human Resources
  • --
  • Michael James Morrissey
  • Executive Vice President and Head of Global Technical Operations
  • --
  • Dr. Pablo J. Cagnoni, M.D.
  • President and Head of Research and Development
  • 15.83M
  • Dr. Otis W. Brawley,M.D.
  • Independent Director
  • 454.76K
  • Julian C. Baker
  • Lead Independent Director
  • 512.76K
  • Dr. Susanne Schaffert, PhD
  • Independent Director
  • 444.76K
  • Dr. Katherine A. High, M.D.
  • Independent Director
  • 454.76K
  • Paul J. Clancy
  • Independent Director
  • 479.76K
  • Dr. Edmund P. Harrigan, M.D.
  • Independent Director
  • 482.26K
  • Jean-Jacques Bienaime
  • Independent Director
  • 478.76K
  • Dr. Jacqualyn A. Fouse, PhD
  • Independent Director
  • 466.26K
Market Insights
Donald Trump Donald Trump

Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.

Symbol Mini Chart % Chg
Trump Media & Technology
DJT
+8.85%
Phunware
PHUN
+6.84%
Tesla
TSLA
+3.50%
Occidental Petroleum
OXY
+2.27%
Strategy
MSTR
+1.81%

Unlock the Full List

Investment Theme ARK Portfolio
ARK Portfolio
Intraday+0.66%
CAR-T Therapy
CAR-T Therapy
Intraday-1.12%